Circulating and tumor-infiltrating myeloid cells predict survival in human pleural mesothelioma.
about
The Potential Protective Effects of Polyphenols in Asbestos-Mediated Inflammation and Carcinogenesis of MesotheliumBiomarkers and prognostic factors for mesotheliomaMesothelioma response to carbon nanotubes is associated with an early and selective accumulation of immunosuppressive monocytic cellsMinimal asbestos exposure in germline BAP1 heterozygous mice is associated with deregulated inflammatory response and increased risk of mesotheliomaThe emerging immunological role of post-translational modifications by reactive nitrogen species in cancer microenvironmentRatio of intratumoral macrophage phenotypes is a prognostic factor in epithelioid malignant pleural mesothelioma.Prognostic significance of tumor-associated macrophages in solid tumor: a meta-analysis of the literature.Interleukin-4 receptor alpha overexpression in human bladder cancer correlates with the pathological grade and stage of the disease.TH2-Polarized CD4(+) T Cells and Macrophages Limit Efficacy of Radiotherapy.Ex vivo enrichment of circulating anti-tumor T cells from both cutaneous and ocular melanoma patients: clinical implications for adoptive cell transfer therapyTrial watch: Prognostic and predictive value of the immune infiltrate in cancerMurine mesothelioma induces locally-proliferating IL-10(+)TNF-α(+)CD206(-)CX3CR1(+) M3 macrophages that can be selectively depleted by chemotherapy or immunotherapy.Inflammation in malignant mesothelioma - friend or foe?Radical surgery for malignant pleural mesothelioma: have we identified the appropriate selection tools?Diagnostic and Prognostic Biomarkers in the Rational Assessment of Mesothelioma (DIAPHRAGM) study: protocol of a prospective, multicentre, observational studyTsc1-Tp53 loss induces mesothelioma in mice, and evidence for this mechanism in human mesothelioma.Identification and manipulation of tumor associated macrophages in human cancers.Dendritic cell-based immunotherapy in mesothelioma.Clinical significance of macrophage heterogeneity in human malignant tumors.Immunotherapy for malignant pleural mesothelioma. Current status and future prospects.Biomarkers and prognostic factors for malignant pleural mesothelioma.Orthotopic Implantation and Peripheral Immune Cell Monitoring in the II-45 Syngeneic Rat Mesothelioma Model.IL-2/CD40-activated macrophages rescue age and tumor-induced T cell dysfunction in elderly mice.Human Tumor-Infiltrating Myeloid Cells: Phenotypic and Functional Diversity.Proteotranscriptomics Reveal Signaling Networks in the Ovarian Cancer Microenvironment.Comprehensive immunoproteogenomic analyses of malignant pleural mesothelioma.How asbestos drives the tissue towards tumors: YAP activation, macrophage and mesothelial precursor recruitment, RNA editing, and somatic mutations.Heterogeneity in Immune Cell Content in Malignant Pleural Mesothelioma.
P2860
Q26750451-D82D1ECB-94F4-4F22-9DC7-C2CCC5CE4CF9Q28387194-4C858F8B-8439-4FF0-B66F-26E0036F841AQ28387268-4EBF26BE-D9A1-4F67-8827-461E38EA1B92Q28389071-3AAB8CA1-7E12-422B-BD3C-9B66E0792FA1Q28396481-675FE530-E30F-4F5F-B636-280BEDE3EA33Q34142500-CDF8022B-8766-494A-8338-715D120AA103Q34531618-17EC1FAC-F16D-4F1B-900A-036BF7B5275BQ34982602-6E31E051-4AF0-4B90-9D3E-9424F779F2A6Q35572179-F74CFF16-9E54-4822-9060-1A87CCCCACD4Q36107158-782820B5-2F57-4261-937B-1711D34D32E8Q36456483-D4F6E7BE-9AE3-457A-B078-18868263BFB5Q37078960-A636E942-B51A-46AD-B065-7C5673134EA3Q37090789-C8908D0D-B838-4D67-91C1-3AA114196181Q37090803-2DF2FC3A-1C23-485B-9392-456AB8AF7AE6Q37516709-FD04CFDC-2E27-4AA8-A3EA-3999E34F302DQ37597672-73776C64-0D15-410B-B7B0-18BBE4E1BDA6Q37969227-48F14D5E-3353-4384-BA08-4C90E8980668Q38059514-61B77674-9671-4495-9025-6508B5D33D40Q38156195-DB1FD0F8-6D54-45B8-A06D-D21385140071Q38180749-A4C118A8-B6E7-448E-BD75-B75C962D64BEQ38660038-575B0C8C-ACD1-4DF0-8EE4-44669F7764B5Q38826424-22D73CFB-02B5-4B69-B163-76C52751832DQ39003110-E63B1913-A281-4037-838A-9731D523D9C7Q39144794-4B1C668E-5CD6-4C6B-9322-834C1BA29251Q47398937-5BD56673-19FC-44FA-AE7C-017154F41A10Q52606456-CBD7D22A-836B-4CB8-A09E-3E17531DBA52Q52728721-B4641758-81EC-4B2C-AE21-C6EFA15F8856Q55481165-8D5A74B2-5374-4001-B4AC-2D5BC8318B25
P2860
Circulating and tumor-infiltrating myeloid cells predict survival in human pleural mesothelioma.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
Circulating and tumor-infiltra ...... in human pleural mesothelioma.
@en
Circulating and tumor-infiltra ...... in human pleural mesothelioma.
@nl
type
label
Circulating and tumor-infiltra ...... in human pleural mesothelioma.
@en
Circulating and tumor-infiltra ...... in human pleural mesothelioma.
@nl
prefLabel
Circulating and tumor-infiltra ...... in human pleural mesothelioma.
@en
Circulating and tumor-infiltra ...... in human pleural mesothelioma.
@nl
P2093
P2860
P356
P1433
P1476
Circulating and tumor-infiltra ...... in human pleural mesothelioma.
@en
P2093
Andrew W Elbardissi
Bryan M Burt
Raphael Bueno
Scott J Rodig
Tamara R Tilleman
P2860
P304
P356
10.1002/CNCR.26143
P407
P577
2011-04-26T00:00:00Z